Exchange: NASDAQ·Updated 08:09 AM EDT
NRIX logo

NRIXNurix Therapeutics Inc

$24.22
$0.04
(0.17%)
Pre-Market
Prev Close $24.26
EarningsJul 9
Mkt Cap$2.51B
Vol11,499.00

About

Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in Brisbane, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
317

Frequently Asked Questions

What is Market Cap of Nurix Therapeutics Inc?
What is the 52-week high for Nurix Therapeutics Inc?
What is the 52-week low for Nurix Therapeutics Inc?
What is Nurix Therapeutics Inc stock price today?
What was Nurix Therapeutics Inc stock price yesterday?
What is the PE ratio of Nurix Therapeutics Inc?
What is the Price-to-Book ratio of Nurix Therapeutics Inc?
What is the 50-day moving average of Nurix Therapeutics Inc?
How many employees does Nurix Therapeutics Inc have?

Advertisement|Remove ads.